Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2024)
Sutro Biopharma (STRO) posted Return on Invested Capital of 0.2% for Q3 2024, down 160.93% sequentially from 0.08% in Q2 2024, and down 16.0% YoY from 0.24% in Q4 2023.
Sutro Biopharma (STRO) Return on Invested Capital (2022 - 2024) Analysis & Trends
Sutro Biopharma has reported Return on Invested Capital for 3 years, with the latest figure at 0.2% in Q3 2024.
- Quarterly Return on Invested Capital fell 16.0% year-over-year to 0.2% in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 0.2% (down 16.0% YoY) and the FY2023 annual result came in at 0.13%, down 1.0% from the prior year.
- Return on Invested Capital eased to 0.2% in Q3 2024 per STRO's latest filing, from 0.08% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.03% in Q1 2023 and troughed at 0.2% in Q3 2024.
- A 3-year average of 0.06% and a median of 0.03% in 2023 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2023 and 2024: Return on Invested Capital changed 0 bps in 2023, then decreased 16 bps in 2024.
- Over 3 years, Return on Invested Capital stood at 0.03% in 2022, then slipped by 2 bps to 0.03% in 2023, then slumped by 616 bps to 0.2% in 2024.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.2%, 0.08%, and 0.03% for Q3 2024, Q2 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.05% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.35% |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -0.20% |
| Jun 30, 2024 | -0.08% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.03% |